Sara Ek
Translational lymphoma group / Immuno-oncology
Our research focuses on finding biological answers to clinically important questions involving improved diagnosis, stratification and treatment of patients with lymphoma.
The main challenge to successfully treat cancer is the heterogeneity of the malignancy, and methods that capture that heterogeneity and provide information on variations in tumour-related signaling pathways and/or interaction with surrounding immune microenvironment is a holy grail.
Molecular investigation
To improve basic understanding and treatment strategies, we perform such detailed molecular investigations of patient material derived from within and outside clinical trials, including sequencing, spatial omics technologies, serum protein profiling and functional screening. Translational bioinformatics is used to bridge between data and clinical practice. Read more about our research on our research page or in Lund University's Research Portal.
Principal Investigator
Sara Ek
Professor
sara [dot] ek [at] immun [dot] lth [dot] se (sara[dot]ek[at]immun[dot]lth[dot]se)
+46-46 222 38 24
Affiliated researchers
Links open personal profiles in Lund University's Research Portal